SlideShare a Scribd company logo
FERMENTATION
PRESENTING BY:
Mr. Purushotham K N
Assistant Professor
Department of Pharma.Chemistry
SACCP
2022-2023
FERMENTATION
• The word Fermentation is derived from Latin word fervere which means to boil.
• But the conventional definition of Fermentation is to break down of larger molecules
into smaller and simple molecules using microorganisms.
• In Biotechnology, Fermentation means any process by which microorganisms are
grown in large quantities to produce any type of useful materials.
• In other words fermentation may be define as the process of growing a culture of
organisms in a nutrient media and thereby converting feed into its desired end product.
Its is sometimes described as biochemical reaction in which microorganisms serve
(bacteria or fungi) as biocatalyst.
Any metabolic process that releases energy from a sugar or other organic molecules,
does not require oxygen or an electron transport system, and uses an organic molecule as
the final electron acceptor.
• This process is carried out in an equipment called as fermentor.
• Fermentor can be defined as a vessel in which sterile nutrient media and pure
culture of microorganism are mixed and fermentation process is carried out under
aseptic and optimum condition.
• The fermentor provides sterile environment, an optimum condition that are
important for microorganism to grow.
TYPES OF INDUSTRIAL FERMENTATION
1. Batch Fermentations
2. Continuous Fermentations
3. Aerobic Fermentations
4. Anaerobic Fermentations
BATCH FERMENTATION:
• A tank of fermenter is filled with the prepared mash of raw materials to be
fermented. 'The temperature and pH for microbial fermentation is properly
adjusted, and occasionally nutritive supplements are added to the prepared mash.
The mash is steam-sterilized in a pure culture process.
• The inoculums ofa pure culture is added to the fennenter, are taken out for further
processing.
• The fermenter is cleaned and the process is repeated. Thus each fermentation is
discontinuous process divided into batches.
CONTINUOUS FERMENTATION
• Growth of microorganisms during batch fermentation confirms to the
characteristic growth curve, with a lag phase followed by a logarithmic phase. is
because of limitation of one or more of The essential nutrients. 'This , in turn, is
terminated by progressive decrements in the essential nutrients.
• In continuous fermentation, the substrate is added to the fermenter continuously at
a fixed rate. 'This maintains the organisms in the logarithmic growth phase .
AEROBIC FERMENTATION:
• A number of industrial processes, although called "fermentations", are carried out
by microorganisms under aerobic conditions.
• In older aerobic processes it was necessary to furnish a large surface area by
exposing fermentation media to air.
• In modern fermentation processes aerobic conditions are maintained in a closed
fermenter with submerged cultures.
• The contents of the fermenter are agitated with auimpeller and aerated by forcing
sterilized air.
ANAEROBIC FERMENTATION:
• Basically a fermenter designed to operate under micro aerophilic conditions will
be the same as that designed to operate under aerobic conditions, except that
arrangements for intense agitation and aeration are unnecessary.
• Many anaerobic fermentations do, however, require mild aeration for the initial
growth phase, and sufficient 'N agitation for mixing and maintenance of
temperature.
Penicillium chrysogenum
• Also known as Penicillium notatum.
• It is common in temperate and subtropical regions and can be found on salted food
products, but it is mostly found in indoor environments, especially in damp or
water-damaged buildings.
• It is the source of several ß-lactam antibiotics, most significantly penicillin which
inhibits the biosynthesis of bacterial cell walls affecting lysis of the cell.
Classification
• Kingdom: Fungi
• Division: Ascomycota
• Class: Eurotiomycetes
• Order: Eurotiales
• Family: Trichocomaceae
• Genus: Penicillium
• Species: Chrysogenum
• Cell structure
• Penicillium chrysogenum exhibits typical eukaryotic cell structure; it has a tubulin
cytoskeleton which is used for motility.
In P. chrysogenum, the conidia are blue to blue-green.
These conidia are the cause of pathogenicity in humans as in the cases of allergy and
endophthalmitis.
The conidia originate from complexes known as conidiophores.
The growth of conidiophores begins when a stalk sprouts out of a foot cell.
The stalk swells at the end and forms a vesicle. Sterigmata form from the vesicle
which give way to long chains of conidia.
Application to Biotechnology
• It produces the hydrophobic ß-lactam compound penicillin.
• Penicillium chrysogenum remains the primary producer of Penicilian G and
Penicilian V
• P. chrysogenum has been used industrially to produce Penicilian G and Penicilian
V and Xanthocillin X, and to produce the enzymes polyamine oxidase,
phosphogluconate dehydrogenase, and glucose oxidase.
• Penicillium chrysogenum can be used to assist crops to fight off other pathogenic
species.
Production of penicillin:
P. chrysogenum is high yielding strain and therefore most widely used as production
strain.
Inoculum Preparation:
Purpose is to develop a pure inoculum in an adequate amount.
To do so various sequential steps are necessary like:
1 A starter culture is needed for inoculation.
2 After getting growth on solid media, one or two growth stages should allowed in
shaken flask cultures to create a suspension, which can be transferred to seed tanks
for further growth.
3 After about 24-28 hours, the content of the seed tanks is transferred to the primary
fermentation tanks.
• All the bio parameters like temperature, PH, aeration,agitation etc. should be
properly maintained.
Bio parameters
• PH: near 6.5
• Temperature: 260C to 280C
• Aeration: a continuous stream of sterilized air is pumped into it.
• Agitation: have baffles which allow constant agitation (200rpm).
Nutrient media
Fermentation broth contains all the necessary elements required for the proliferation
of the microorganisms.
Generally, it contains a carbon source, nitrogen source,mineral source, precrsors and
antifoam agents.
Carbon Source Lactose in concentration of 6%.
Other carbohydrates like glucose & sucrose.
Complex as well as cheap sources like molasses, orsoya meal can also be used
which are made up of lactose and glucose sugars.
• Nitrogen Source
• Ammonium salts such as ammonium sulphate,
• ammonium acetate, ammonium lactate or ammonia gas
• are used for this reason.
• Sometime corn steep liquor may be used.
• Mineral Source
• These elements include phosphorus, sulphur,
• magnesium, zinc, iron, and copper which generally
• added in the fom of water soluble salts.
• Precursors
• Various types of precursors are added into production
• medium to produce specific type of penicillin.
For example, if phenyl acetic acid is provided then only penicillin-G will be produced
but if hydroxy phenyl acetic acid is provided then penicillin-X will be produced.
Phenoxy acetic acid is provided as precursor for penicillin-V production.
corn steep liquor is provided as nitrogen source, When it also provides phenyl acetic
acid derivatives; therefore it is widely used in the production of penicillin-G.
Anti-foam agents
Anti-foaming agents such as lard oil, octadecanol and silicones are used to prevent
foaming during fermentation.
Recovery
The recovery of penicillin is carried out in three
successive stages:
1. Removal of mycelium
2. Counter current solvent extraction of penicillin
3. Treatment of crude extracts
At harvest the fermentation broth is filtered on a rotatory vacuum filter to remove the
mycelium and other solids.
Phosphoric or sulfuric acids are added to lower the pH (2 to2.5) in order to transform
the penicillin to the aniomc form.
Then the broth is directly extracted in a Podbielniak Counter Current Solvent Extractor
with an organic solvent.
such as methyl isobutyl ketone, amyl acetate or butyl acetate.
Penicillin is then again extracted into water from the organic solvent by adding an
adequate amount of potassium or sodium hydroxide to form a salt of the penicillin.
The resulting aqueous solution is again acidified & re-extracted with methyl isobutyl
ketone.
This shifts between water and solvent help in purification of the penicillin.
The solvent extract is carefully back extracted with NaOH and from this aqueous
solution; various
procedures are utilized to cause the penicillin to crystalize as sodium or potassium
penicillinate.
The resulting crystalline penicillin salts are then washed and dried.
Sometimes the crude extract of penicillin is passed out from charcoal treatment to
eliminate pyrogens; even sterilization can also be done.
Flow diagram for Penicillin G Production
Master stock of P. chrysogenum
Sporulation (flask culture)
Spore suspension
Germination /seed tank
Production fermenter
Filtration
Filtrate
Streptomycin
Streptomycin is an antibiotic
It was discovered by Schatz, Bugie and Waksman (1944) in one of the soil isolates
Streptomyces griseus.
Most of the industry used this parent strain for streptomycin production today also.
Mutation and selection employed to increase yields to the present day levels.
But,nowadays also Streptomycin is produced by Streptomyces griseus and only a
few strains of this organism have the ability to produce reasonable yields of the
antibiotic.
It is active against gram Positive and Negative bacteria and against the tuberculosis
organism Mycobacterium tuberculi.
Uses
• It has been used therapeutically in the treatment of infections caused by organisms
resistant to Penicillin
• It is also used in the treatment of plant diseases caused by bacteria
• It is used in the treatment of tuberculosis caused by Mycobacterium tuberculi.
Chemical structure:
• Streptomycin and dihydrostreptomycin are basic compounds.
• They are usually prepared as salts.
• Streptomycin is available as the hydrochloride C21H39N202.3HCL as a
crystalline hydrochloride double salt with calcium chloride or as the
• phosphate or sulphate Dihydrostreptomycin as the hydrochloride or Sulfate.
• Depending on the strain of this organism being used or on the production of
medium,small amounts of mannosidostreptomycin or hydroxy streptomycin are
accumulated in addition to streptomycin
• Some mannosido streptomycin is produced early in the fermentation, but this
antibioticis largely enzymatically degraded by Streptomyces griseus to
sterptyomycin at the time of harvest.
• the mannosidostreptomycin is not desired because of its low antibiotic activity.
• The use of precursors does not increase yields of streptomycin.
• Most of the carbon of the streptomycin molecule has shown to originate from
glucose and not from the more complex carbon compounds of the medium ,
although some of the carbon molecule originate from carbon di oxide.
• The carbonyl function on the streptose moiety is involved in the antibiotic activity
of streptomycin.
• Most chemical additions to the carbonyl group destroy the antibiotic activity.
Production —medium
Two types of medium were used
1. Woodruff and Mc. Daniel (1954)
1% soyabean meal
1% glucose
0.5% sodium chloride
2. Hockenhull (1963)
2.5% glucose
4% soyabean meal
0.5% distillers dried soluble
0.25% sodium chloride
pH -7-3 to 7-5 before sterilization
Inoculum preparation
High yielding mutated strains of Streptomyces griseus are genetically unstable , a
fact to be considered in maintenance of stock cultures.
Because of this consideration, spores of the organism usually are maintain soil
stocks or are lyophilized in a carrier such as sterile skim milk .
Spores from these stock cultures are then transferred to a sporulation medium to
sporulated to initiate liquid culture buildup of growth
mycelial inoculum in flasks or inoculum tanks.
STREPTOMYCIN PRODUCTION
Commercial streptomycin fermentation passes through three phases:
I phase: lasts approximately 24hours.
With rapid growth of the mycelium.
Proteolytic activity of streptomyces griseus releases ammonia to the medium from
the soyabean meal.
Carbon nutrients of the medium utilized for the growth
Glucose of the medium is utilized slowly during this period
Only slight streptomycin production occurs
During this period, the pH of the medium rises from approximately 6.7 or 6.8 to 7-5
or slightly higher
II phase
Streptomycin is produced at high rate
Lasts approximately 24 hours to 6 or7 days of incubation
Almost, no mycelium growth, weight of the mycelium remains constant
The ammonia is utilized and the pH remains fairly constant in a range of
approximately about 7.6-8
Glucose and oxygen are required in a large quantity.
III phase
• Sugar has been depleted from the medium
• Streptomycin production ceases
• Mycelium undergoes autolysis,releasing ammonia and the pH value rises
• The fermentation , however usually is harvested before cell lysis.
Harvest and Recovery of streptomycin
After completion of fermentation the mycelium is separated from the broth by
filtration. Streptomycin is recovered by several methods. The choice of procedure
depending on the industrial concern.
In one procedure,
The streptomycin is adsorbed from the broth onto the activated carbon and then
eluted from the carbon with dilute acid. The eluted streptomycin is precipitated by
acetone, filtered and dried before further purification.
In an alternative procedure,
The fermentation broth is acidified, filtered and neutralized. It is then passed
through a column containing a cation exchange resin to adsorb the streptomycin
from the broth.
The column is then washed with water and theantibiotic is eluted with hydrochloric
acid or cyclohexanol or phosphoric acid. It is then concentrated at about 600C under
vacuum almost to dryness.
The streptomycin is then dissolved in methanol and filtered and acetone is added to
the filtrate to precipitate the antibiotic. The precipitate is again washed with acetone
and vacuum dried.
It is purified further by dissolving in methanol. The streptomycin in
pure form is extracted as calcium chloride complex.
vitamins
 Vitamins are essential micronutrients required in trace quantities that cannot be
synthesized by mammals.
 They are essential for metabolism for all living organism
 presently few of the vitamins are chemically synthesized or via extraction
processes.
Vitamin B 12 also known as cyanocobalamin, is a water-soluble vitamin
with a key role in normal functioning of the brain, nervous system and
for the formation of blood.
Structure of Vitamin B12
• The chemical structure of the molecule was determined by Dorothy
crowfoot Hodgkin and her team in 1956 based on crystallographic
data.
MICRO-ORGANISM IN INDUSTRIAL
PRODUCTION OF VITAMIN B12
Streptomyces griseus,
S. olivaceus,
Bacillus megaterium,
Pseudomonas denitrificans,
Propionibacterium freudenreichii,
P. Shremanii & mixed fermentation of a proteus spp and a pseudomonas sp.
Manufactured by submerged fermentation
Aeration and agitation of medium essential
Fermentation process completed in 3 to 5 days
Vitamin B 12 production using
Streptomyces olivaceus NRRL B-1125
Pure slant culture of streptomyces olivaceus NRRL B 1125 is inoculated
and grown in 100 to 250 ml of inoculum medium.
Seeded flask are kept on shaker for incubation
Flask cultures are used to inoculate large amount of inoculum media
arranged in series of tank
Two or three successive transfers are made to obtain required amount of
inoculum cultures.
Vitamin B2/Riboflavin
Microorganism in industrial production of Vitamin B 2
Production process of riboflavin
• Industrial production of riboflavin is mostly carried out with the organism,
Ashbya gossypii by using simple sugars such as glucose and corn steep liquor.
• Glucose can be replaced by sucrose or maltose for the supply of carbon source.
• In recent years, lipids such as corn oil, when added to the medium for energy
purpose, have a profound influence on riboflavin production.
• Further, supplementation of the medium with yeast extract, peptones, glycine,
inositol, purines also increase the yield of riboflavin.
• It is essential to carefully sterilize the medium for good yield of riboflavin.
• The initial pH of the culture medium is adjusted to around 6- 7.5.
• The fermentation is conducted at temperature 26-28°C with an aeration rate
0.3 vvm.
• The process is carried out for about 5-7 days by submerged aerated
fermentation.
• Fermentation through phases:
• Phase I: This phase is characterized by rapid growth of the organism utilizing
glucose.
• As pyruvic acid accumulates, pH becomes acidic.
• The growth of the organism stops as glucose gets exhausted. In phase I, there is no
production of riboflavin.
• Phase II: Sporulation occurs in this phase, and pyruvate concentration decreases.
Simultaneously, there is an accumulation of ammonia (due to enhanced deaminase
activity) which makes the medium alkaline.
• Phase II is characterized by a maximal production of riboflavin. But this is mostly
in the form of FAD and a small portion of it as FMN.
Phase III: In this last phase, cells get disrupted by a process of
autolysis. This allows release of FAD, FMN and free riboflavin into the
medium.
• Recovery: Riboflavin is found in fermentation broth and in a bound
form to the cells. The latter can be released by heat treatment i.e. 120°C
for about 1 hour.
• The cells can be discarded after filtration or centrifugation. The filtrate
can be further purified and dried, as per the requirements.
STATINS
 Hyper-lipoproteinemias (HPL) are conditions in which the concentration of cholesterol or
triglyceride carrying lipoproteins in the plasma is elevated above normal.
 Increase in lipoprotein can hasten the development of atherosclerosis and is a risk factors
for myocardial infarction (MI)
 Lipids and proteins form complexes called lipoproteins & circulate in blood vessels.
Hypolipidaemias
• These are the drugs which lower the levels of lipids and lipoproteins in blood used to
prevent cardiovascular disease by retarding the atherosclerosis in hyper-lipidaemia
individuals
• Drugs used to treat hyperlipidaemia are
 Lovastatin, Simvastatin, Atorvastatin
 Cholestyramine, Colestipol
 Clofibrate, Gemfibrozil
 Nicotinic Acid
Mechanism of Action of Statins (HMG CoA
reductase Inhibitors)
• Hydroxymethyl glutaryl CoA is the rate controlling enzyme in the biosynthesis of cholesterol
• Lovastatin and its congeners are structurally similar to HMG CoA and therefore competitive
inhibitors of the enzyme HMG-CoA reductase. The synthesis of cholesterol in the liver is reduced.
There is an increase in the expression of hepatic LDL receptor. So that more of LDL is taken up
from the circulation. As a result plasma levels of LDL cholesterol and triglycerides fall.
• Concentration of HDL- cholesterol increases by 10%
Statins
Inhibit the HMG CoA reductase
Decrease synthesis of Cholesterol
Decrease LDL
Statins to be useful lowering morbidity and mortality in patients with coronary heart
disease. Hence they are used in patients with MI, angina etc
 Lovastatin was the first statin drug which was approved by USFDA In the
year 1987
 It is a potent drug that is used to control increased serum cholesterol level,
there by preventing hypercholesterolemia and associated health issue.
 It is a competitive inhibitor of the enzyme HMG CoA reductase which
catalyses rate limiting step in cholesterol biosynthesis
Fungal organism reported for lovastatin
production
• Aspergillus
• Penicillium citrinum
• Monascus ruber
• Trichoderma
• Pleurotus widely reported soil fungi capable of lovastatin production
• Commercial production of lovastatin employs a Aspergillus terreus soil fungus
• Several production media have been evaluated for lovastatin production by SmF ( submerged fermentation)
• Increased yield by supplementation with carbon, nitrogen, aminoacids, vitamins, etc.
Fermentation Techniques
• Different fermentation techniques including solid state fermentation (SSF)
and submerged fermentation (SMF) can be used for statin production.
• Large scale commercial production utilises submerged batch fermentation
• There is a controlled aeration & agitation in a bioreactor during SMF, which
increases the oxygen mass transfer and constant distribution of nutrients to
fungal mycelia, resulting in increased production of statins.
Wheat bran (40g) as substrate
Inoculated with spore suspension (107/8ml spores) of A. terreus
(KM017963)
Incubated at 280C for 7 days
Materials and Methods
Culturing of Aspergillus terreus by Solid State Fermentation (SSF)
EXTRACTION
Inoculated substrate was dried at 40◦C for 24h
Crushed to powder
Ethyl acetate (150 ml) was added
Filtrate was dried using rotary vacuum evaporator
Purification of lovastatin
One gram of dried crude lovastatin extract was loaded on to pre-
packed silica gel column
Elution with benzene (100%), and combination of
Benzene: Acetonitrile in the following ratio 95:5, 90:10, 85:15, 80:20
Acetonitrile (100%)
Thin Layer Chromatography (TLC)
Detection of Lovastatin by Thin Layer
Chromatography (TLC)
Organic phase (20 µl) was spotted on TLC plate
Dichloromethane: Ethyl acetate (70:30)
Rf comparison with standard Lovastatin
THANK YOU

More Related Content

Similar to FERMENTATION.pptx

Industrial microbiology
Industrial microbiologyIndustrial microbiology
Industrial microbiology
anjusha suki
 
Large scale production of antibiotics.pptx
Large scale production of antibiotics.pptxLarge scale production of antibiotics.pptx
Large scale production of antibiotics.pptx
AkhilS634645
 
Fermentation of penicillin antibiotic
Fermentation of penicillin antibiotic Fermentation of penicillin antibiotic
Fermentation of penicillin antibiotic
VivaMariyaVarghese
 
Fermentationtechnology (biotech)
Fermentationtechnology (biotech)Fermentationtechnology (biotech)
Fermentationtechnology (biotech)
Subhashree7873
 
Fermentation final ppt
Fermentation final pptFermentation final ppt
Fermentation final ppt
Rina Patil
 
Penicillin production by Likhith K
Penicillin production by Likhith KPenicillin production by Likhith K
Penicillin production by Likhith K
LIKHITHK1
 
Fermentation-technology BC.ppt
Fermentation-technology BC.pptFermentation-technology BC.ppt
Fermentation-technology BC.ppt
SanthoshBc3
 
Production of-antibiotic ppt
Production of-antibiotic pptProduction of-antibiotic ppt
Production of-antibiotic ppt
Ibad khan
 
1production of-antibiotic-181225165848
1production of-antibiotic-1812251658481production of-antibiotic-181225165848
1production of-antibiotic-181225165848
farahcantiq
 
FERMENTATION..pptx
FERMENTATION..pptxFERMENTATION..pptx
FERMENTATION..pptx
TejaswiniAsawa
 
1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx
alizain9604
 
1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx
alizain9604
 
Fermentation
FermentationFermentation
Fermentation
ROHIT PAL
 
SINGLE CELL PROTEIN
SINGLE CELL PROTEINSINGLE CELL PROTEIN
SINGLE CELL PROTEIN
TANISHKA RAJESH KUMAR
 
Fermentation technology
Fermentation technologyFermentation technology
Fermentation technology
Amrita Sutradhar
 
Production Of Pharamaceuticals (1).pptx
Production Of Pharamaceuticals (1).pptxProduction Of Pharamaceuticals (1).pptx
Production Of Pharamaceuticals (1).pptx
TejaswiniAsawa
 
Ferementation
FerementationFerementation
production of penicillin b pharma 6th sem by piyush lodhi
production of penicillin b pharma 6th sem by piyush lodhiproduction of penicillin b pharma 6th sem by piyush lodhi
production of penicillin b pharma 6th sem by piyush lodhi
Drx Piyush Lodhi
 
Antimicrobial
AntimicrobialAntimicrobial
Antimicrobial
HanaaHaykal
 
Microbial growth stages
Microbial growth stagesMicrobial growth stages
Microbial growth stages
Ahmed Abdellatif
 

Similar to FERMENTATION.pptx (20)

Industrial microbiology
Industrial microbiologyIndustrial microbiology
Industrial microbiology
 
Large scale production of antibiotics.pptx
Large scale production of antibiotics.pptxLarge scale production of antibiotics.pptx
Large scale production of antibiotics.pptx
 
Fermentation of penicillin antibiotic
Fermentation of penicillin antibiotic Fermentation of penicillin antibiotic
Fermentation of penicillin antibiotic
 
Fermentationtechnology (biotech)
Fermentationtechnology (biotech)Fermentationtechnology (biotech)
Fermentationtechnology (biotech)
 
Fermentation final ppt
Fermentation final pptFermentation final ppt
Fermentation final ppt
 
Penicillin production by Likhith K
Penicillin production by Likhith KPenicillin production by Likhith K
Penicillin production by Likhith K
 
Fermentation-technology BC.ppt
Fermentation-technology BC.pptFermentation-technology BC.ppt
Fermentation-technology BC.ppt
 
Production of-antibiotic ppt
Production of-antibiotic pptProduction of-antibiotic ppt
Production of-antibiotic ppt
 
1production of-antibiotic-181225165848
1production of-antibiotic-1812251658481production of-antibiotic-181225165848
1production of-antibiotic-181225165848
 
FERMENTATION..pptx
FERMENTATION..pptxFERMENTATION..pptx
FERMENTATION..pptx
 
1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx
 
1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx1production-of-antibiotic-181225165848.pptx
1production-of-antibiotic-181225165848.pptx
 
Fermentation
FermentationFermentation
Fermentation
 
SINGLE CELL PROTEIN
SINGLE CELL PROTEINSINGLE CELL PROTEIN
SINGLE CELL PROTEIN
 
Fermentation technology
Fermentation technologyFermentation technology
Fermentation technology
 
Production Of Pharamaceuticals (1).pptx
Production Of Pharamaceuticals (1).pptxProduction Of Pharamaceuticals (1).pptx
Production Of Pharamaceuticals (1).pptx
 
Ferementation
FerementationFerementation
Ferementation
 
production of penicillin b pharma 6th sem by piyush lodhi
production of penicillin b pharma 6th sem by piyush lodhiproduction of penicillin b pharma 6th sem by piyush lodhi
production of penicillin b pharma 6th sem by piyush lodhi
 
Antimicrobial
AntimicrobialAntimicrobial
Antimicrobial
 
Microbial growth stages
Microbial growth stagesMicrobial growth stages
Microbial growth stages
 

More from PurushothamKN1

Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptxChemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
PurushothamKN1
 
SAR of Quinolines.pptx
SAR of Quinolines.pptxSAR of Quinolines.pptx
SAR of Quinolines.pptx
PurushothamKN1
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
PurushothamKN1
 
modify of peptidomimetics.pptx
modify of peptidomimetics.pptxmodify of peptidomimetics.pptx
modify of peptidomimetics.pptx
PurushothamKN1
 
INDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptxINDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptx
PurushothamKN1
 
.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx
PurushothamKN1
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
PurushothamKN1
 
01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx
PurushothamKN1
 
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
PurushothamKN1
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
PurushothamKN1
 
Adrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptxAdrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptx
PurushothamKN1
 
analog design.pptx
analog design.pptxanalog design.pptx
analog design.pptx
PurushothamKN1
 
anti hypertensive agents.pptx
anti hypertensive agents.pptxanti hypertensive agents.pptx
anti hypertensive agents.pptx
PurushothamKN1
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
PurushothamKN1
 
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptxChemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
PurushothamKN1
 
COX.pptx
COX.pptxCOX.pptx
COX.pptx
PurushothamKN1
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
PurushothamKN1
 
peptidomimetics.pptx
peptidomimetics.pptxpeptidomimetics.pptx
peptidomimetics.pptx
PurushothamKN1
 
prinz metal angina.pptx
prinz metal angina.pptxprinz metal angina.pptx
prinz metal angina.pptx
PurushothamKN1
 
prodrug.pptx
prodrug.pptxprodrug.pptx
prodrug.pptx
PurushothamKN1
 

More from PurushothamKN1 (20)

Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptxChemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
 
SAR of Quinolines.pptx
SAR of Quinolines.pptxSAR of Quinolines.pptx
SAR of Quinolines.pptx
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
 
modify of peptidomimetics.pptx
modify of peptidomimetics.pptxmodify of peptidomimetics.pptx
modify of peptidomimetics.pptx
 
INDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptxINDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptx
 
.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
 
01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx
 
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
 
Adrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptxAdrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptx
 
analog design.pptx
analog design.pptxanalog design.pptx
analog design.pptx
 
anti hypertensive agents.pptx
anti hypertensive agents.pptxanti hypertensive agents.pptx
anti hypertensive agents.pptx
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
 
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptxChemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
 
COX.pptx
COX.pptxCOX.pptx
COX.pptx
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
 
peptidomimetics.pptx
peptidomimetics.pptxpeptidomimetics.pptx
peptidomimetics.pptx
 
prinz metal angina.pptx
prinz metal angina.pptxprinz metal angina.pptx
prinz metal angina.pptx
 
prodrug.pptx
prodrug.pptxprodrug.pptx
prodrug.pptx
 

Recently uploaded

The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 

Recently uploaded (20)

The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 

FERMENTATION.pptx

  • 1. FERMENTATION PRESENTING BY: Mr. Purushotham K N Assistant Professor Department of Pharma.Chemistry SACCP 2022-2023
  • 2. FERMENTATION • The word Fermentation is derived from Latin word fervere which means to boil. • But the conventional definition of Fermentation is to break down of larger molecules into smaller and simple molecules using microorganisms. • In Biotechnology, Fermentation means any process by which microorganisms are grown in large quantities to produce any type of useful materials. • In other words fermentation may be define as the process of growing a culture of organisms in a nutrient media and thereby converting feed into its desired end product. Its is sometimes described as biochemical reaction in which microorganisms serve (bacteria or fungi) as biocatalyst. Any metabolic process that releases energy from a sugar or other organic molecules, does not require oxygen or an electron transport system, and uses an organic molecule as the final electron acceptor.
  • 3. • This process is carried out in an equipment called as fermentor. • Fermentor can be defined as a vessel in which sterile nutrient media and pure culture of microorganism are mixed and fermentation process is carried out under aseptic and optimum condition. • The fermentor provides sterile environment, an optimum condition that are important for microorganism to grow.
  • 4. TYPES OF INDUSTRIAL FERMENTATION 1. Batch Fermentations 2. Continuous Fermentations 3. Aerobic Fermentations 4. Anaerobic Fermentations
  • 5. BATCH FERMENTATION: • A tank of fermenter is filled with the prepared mash of raw materials to be fermented. 'The temperature and pH for microbial fermentation is properly adjusted, and occasionally nutritive supplements are added to the prepared mash. The mash is steam-sterilized in a pure culture process. • The inoculums ofa pure culture is added to the fennenter, are taken out for further processing. • The fermenter is cleaned and the process is repeated. Thus each fermentation is discontinuous process divided into batches.
  • 6. CONTINUOUS FERMENTATION • Growth of microorganisms during batch fermentation confirms to the characteristic growth curve, with a lag phase followed by a logarithmic phase. is because of limitation of one or more of The essential nutrients. 'This , in turn, is terminated by progressive decrements in the essential nutrients. • In continuous fermentation, the substrate is added to the fermenter continuously at a fixed rate. 'This maintains the organisms in the logarithmic growth phase .
  • 7. AEROBIC FERMENTATION: • A number of industrial processes, although called "fermentations", are carried out by microorganisms under aerobic conditions. • In older aerobic processes it was necessary to furnish a large surface area by exposing fermentation media to air. • In modern fermentation processes aerobic conditions are maintained in a closed fermenter with submerged cultures. • The contents of the fermenter are agitated with auimpeller and aerated by forcing sterilized air.
  • 8. ANAEROBIC FERMENTATION: • Basically a fermenter designed to operate under micro aerophilic conditions will be the same as that designed to operate under aerobic conditions, except that arrangements for intense agitation and aeration are unnecessary. • Many anaerobic fermentations do, however, require mild aeration for the initial growth phase, and sufficient 'N agitation for mixing and maintenance of temperature.
  • 9. Penicillium chrysogenum • Also known as Penicillium notatum. • It is common in temperate and subtropical regions and can be found on salted food products, but it is mostly found in indoor environments, especially in damp or water-damaged buildings. • It is the source of several ß-lactam antibiotics, most significantly penicillin which inhibits the biosynthesis of bacterial cell walls affecting lysis of the cell.
  • 10. Classification • Kingdom: Fungi • Division: Ascomycota • Class: Eurotiomycetes • Order: Eurotiales • Family: Trichocomaceae • Genus: Penicillium • Species: Chrysogenum • Cell structure • Penicillium chrysogenum exhibits typical eukaryotic cell structure; it has a tubulin cytoskeleton which is used for motility.
  • 11. In P. chrysogenum, the conidia are blue to blue-green. These conidia are the cause of pathogenicity in humans as in the cases of allergy and endophthalmitis. The conidia originate from complexes known as conidiophores. The growth of conidiophores begins when a stalk sprouts out of a foot cell. The stalk swells at the end and forms a vesicle. Sterigmata form from the vesicle which give way to long chains of conidia.
  • 12. Application to Biotechnology • It produces the hydrophobic ß-lactam compound penicillin. • Penicillium chrysogenum remains the primary producer of Penicilian G and Penicilian V • P. chrysogenum has been used industrially to produce Penicilian G and Penicilian V and Xanthocillin X, and to produce the enzymes polyamine oxidase, phosphogluconate dehydrogenase, and glucose oxidase. • Penicillium chrysogenum can be used to assist crops to fight off other pathogenic species.
  • 13. Production of penicillin: P. chrysogenum is high yielding strain and therefore most widely used as production strain. Inoculum Preparation: Purpose is to develop a pure inoculum in an adequate amount. To do so various sequential steps are necessary like: 1 A starter culture is needed for inoculation. 2 After getting growth on solid media, one or two growth stages should allowed in shaken flask cultures to create a suspension, which can be transferred to seed tanks for further growth. 3 After about 24-28 hours, the content of the seed tanks is transferred to the primary fermentation tanks.
  • 14. • All the bio parameters like temperature, PH, aeration,agitation etc. should be properly maintained. Bio parameters • PH: near 6.5 • Temperature: 260C to 280C • Aeration: a continuous stream of sterilized air is pumped into it. • Agitation: have baffles which allow constant agitation (200rpm).
  • 15. Nutrient media Fermentation broth contains all the necessary elements required for the proliferation of the microorganisms. Generally, it contains a carbon source, nitrogen source,mineral source, precrsors and antifoam agents. Carbon Source Lactose in concentration of 6%. Other carbohydrates like glucose & sucrose. Complex as well as cheap sources like molasses, orsoya meal can also be used which are made up of lactose and glucose sugars.
  • 16. • Nitrogen Source • Ammonium salts such as ammonium sulphate, • ammonium acetate, ammonium lactate or ammonia gas • are used for this reason. • Sometime corn steep liquor may be used. • Mineral Source • These elements include phosphorus, sulphur, • magnesium, zinc, iron, and copper which generally • added in the fom of water soluble salts. • Precursors • Various types of precursors are added into production • medium to produce specific type of penicillin.
  • 17. For example, if phenyl acetic acid is provided then only penicillin-G will be produced but if hydroxy phenyl acetic acid is provided then penicillin-X will be produced. Phenoxy acetic acid is provided as precursor for penicillin-V production. corn steep liquor is provided as nitrogen source, When it also provides phenyl acetic acid derivatives; therefore it is widely used in the production of penicillin-G. Anti-foam agents Anti-foaming agents such as lard oil, octadecanol and silicones are used to prevent foaming during fermentation. Recovery The recovery of penicillin is carried out in three successive stages: 1. Removal of mycelium 2. Counter current solvent extraction of penicillin 3. Treatment of crude extracts
  • 18. At harvest the fermentation broth is filtered on a rotatory vacuum filter to remove the mycelium and other solids. Phosphoric or sulfuric acids are added to lower the pH (2 to2.5) in order to transform the penicillin to the aniomc form. Then the broth is directly extracted in a Podbielniak Counter Current Solvent Extractor with an organic solvent. such as methyl isobutyl ketone, amyl acetate or butyl acetate. Penicillin is then again extracted into water from the organic solvent by adding an adequate amount of potassium or sodium hydroxide to form a salt of the penicillin. The resulting aqueous solution is again acidified & re-extracted with methyl isobutyl ketone.
  • 19. This shifts between water and solvent help in purification of the penicillin. The solvent extract is carefully back extracted with NaOH and from this aqueous solution; various procedures are utilized to cause the penicillin to crystalize as sodium or potassium penicillinate. The resulting crystalline penicillin salts are then washed and dried. Sometimes the crude extract of penicillin is passed out from charcoal treatment to eliminate pyrogens; even sterilization can also be done.
  • 20. Flow diagram for Penicillin G Production Master stock of P. chrysogenum Sporulation (flask culture) Spore suspension Germination /seed tank Production fermenter Filtration Filtrate
  • 21. Streptomycin Streptomycin is an antibiotic It was discovered by Schatz, Bugie and Waksman (1944) in one of the soil isolates Streptomyces griseus. Most of the industry used this parent strain for streptomycin production today also. Mutation and selection employed to increase yields to the present day levels. But,nowadays also Streptomycin is produced by Streptomyces griseus and only a few strains of this organism have the ability to produce reasonable yields of the antibiotic. It is active against gram Positive and Negative bacteria and against the tuberculosis organism Mycobacterium tuberculi.
  • 22. Uses • It has been used therapeutically in the treatment of infections caused by organisms resistant to Penicillin • It is also used in the treatment of plant diseases caused by bacteria • It is used in the treatment of tuberculosis caused by Mycobacterium tuberculi.
  • 23. Chemical structure: • Streptomycin and dihydrostreptomycin are basic compounds. • They are usually prepared as salts. • Streptomycin is available as the hydrochloride C21H39N202.3HCL as a crystalline hydrochloride double salt with calcium chloride or as the • phosphate or sulphate Dihydrostreptomycin as the hydrochloride or Sulfate. • Depending on the strain of this organism being used or on the production of medium,small amounts of mannosidostreptomycin or hydroxy streptomycin are accumulated in addition to streptomycin • Some mannosido streptomycin is produced early in the fermentation, but this antibioticis largely enzymatically degraded by Streptomyces griseus to sterptyomycin at the time of harvest.
  • 24. • the mannosidostreptomycin is not desired because of its low antibiotic activity. • The use of precursors does not increase yields of streptomycin. • Most of the carbon of the streptomycin molecule has shown to originate from glucose and not from the more complex carbon compounds of the medium , although some of the carbon molecule originate from carbon di oxide. • The carbonyl function on the streptose moiety is involved in the antibiotic activity of streptomycin. • Most chemical additions to the carbonyl group destroy the antibiotic activity.
  • 25. Production —medium Two types of medium were used 1. Woodruff and Mc. Daniel (1954) 1% soyabean meal 1% glucose 0.5% sodium chloride 2. Hockenhull (1963) 2.5% glucose 4% soyabean meal 0.5% distillers dried soluble 0.25% sodium chloride pH -7-3 to 7-5 before sterilization
  • 26. Inoculum preparation High yielding mutated strains of Streptomyces griseus are genetically unstable , a fact to be considered in maintenance of stock cultures. Because of this consideration, spores of the organism usually are maintain soil stocks or are lyophilized in a carrier such as sterile skim milk . Spores from these stock cultures are then transferred to a sporulation medium to sporulated to initiate liquid culture buildup of growth mycelial inoculum in flasks or inoculum tanks.
  • 27. STREPTOMYCIN PRODUCTION Commercial streptomycin fermentation passes through three phases: I phase: lasts approximately 24hours. With rapid growth of the mycelium. Proteolytic activity of streptomyces griseus releases ammonia to the medium from the soyabean meal. Carbon nutrients of the medium utilized for the growth Glucose of the medium is utilized slowly during this period Only slight streptomycin production occurs During this period, the pH of the medium rises from approximately 6.7 or 6.8 to 7-5 or slightly higher
  • 28. II phase Streptomycin is produced at high rate Lasts approximately 24 hours to 6 or7 days of incubation Almost, no mycelium growth, weight of the mycelium remains constant The ammonia is utilized and the pH remains fairly constant in a range of approximately about 7.6-8 Glucose and oxygen are required in a large quantity.
  • 29. III phase • Sugar has been depleted from the medium • Streptomycin production ceases • Mycelium undergoes autolysis,releasing ammonia and the pH value rises • The fermentation , however usually is harvested before cell lysis.
  • 30. Harvest and Recovery of streptomycin After completion of fermentation the mycelium is separated from the broth by filtration. Streptomycin is recovered by several methods. The choice of procedure depending on the industrial concern. In one procedure, The streptomycin is adsorbed from the broth onto the activated carbon and then eluted from the carbon with dilute acid. The eluted streptomycin is precipitated by acetone, filtered and dried before further purification.
  • 31. In an alternative procedure, The fermentation broth is acidified, filtered and neutralized. It is then passed through a column containing a cation exchange resin to adsorb the streptomycin from the broth. The column is then washed with water and theantibiotic is eluted with hydrochloric acid or cyclohexanol or phosphoric acid. It is then concentrated at about 600C under vacuum almost to dryness. The streptomycin is then dissolved in methanol and filtered and acetone is added to the filtrate to precipitate the antibiotic. The precipitate is again washed with acetone and vacuum dried. It is purified further by dissolving in methanol. The streptomycin in pure form is extracted as calcium chloride complex.
  • 32. vitamins  Vitamins are essential micronutrients required in trace quantities that cannot be synthesized by mammals.  They are essential for metabolism for all living organism  presently few of the vitamins are chemically synthesized or via extraction processes.
  • 33. Vitamin B 12 also known as cyanocobalamin, is a water-soluble vitamin with a key role in normal functioning of the brain, nervous system and for the formation of blood.
  • 34. Structure of Vitamin B12 • The chemical structure of the molecule was determined by Dorothy crowfoot Hodgkin and her team in 1956 based on crystallographic data.
  • 35.
  • 36.
  • 37.
  • 38. MICRO-ORGANISM IN INDUSTRIAL PRODUCTION OF VITAMIN B12 Streptomyces griseus, S. olivaceus, Bacillus megaterium, Pseudomonas denitrificans, Propionibacterium freudenreichii, P. Shremanii & mixed fermentation of a proteus spp and a pseudomonas sp.
  • 39. Manufactured by submerged fermentation Aeration and agitation of medium essential Fermentation process completed in 3 to 5 days
  • 40. Vitamin B 12 production using Streptomyces olivaceus NRRL B-1125 Pure slant culture of streptomyces olivaceus NRRL B 1125 is inoculated and grown in 100 to 250 ml of inoculum medium. Seeded flask are kept on shaker for incubation Flask cultures are used to inoculate large amount of inoculum media arranged in series of tank Two or three successive transfers are made to obtain required amount of inoculum cultures.
  • 41.
  • 42.
  • 43.
  • 45. Microorganism in industrial production of Vitamin B 2
  • 46. Production process of riboflavin • Industrial production of riboflavin is mostly carried out with the organism, Ashbya gossypii by using simple sugars such as glucose and corn steep liquor. • Glucose can be replaced by sucrose or maltose for the supply of carbon source. • In recent years, lipids such as corn oil, when added to the medium for energy purpose, have a profound influence on riboflavin production. • Further, supplementation of the medium with yeast extract, peptones, glycine, inositol, purines also increase the yield of riboflavin.
  • 47. • It is essential to carefully sterilize the medium for good yield of riboflavin. • The initial pH of the culture medium is adjusted to around 6- 7.5. • The fermentation is conducted at temperature 26-28°C with an aeration rate 0.3 vvm. • The process is carried out for about 5-7 days by submerged aerated fermentation.
  • 48. • Fermentation through phases: • Phase I: This phase is characterized by rapid growth of the organism utilizing glucose. • As pyruvic acid accumulates, pH becomes acidic. • The growth of the organism stops as glucose gets exhausted. In phase I, there is no production of riboflavin. • Phase II: Sporulation occurs in this phase, and pyruvate concentration decreases. Simultaneously, there is an accumulation of ammonia (due to enhanced deaminase activity) which makes the medium alkaline. • Phase II is characterized by a maximal production of riboflavin. But this is mostly in the form of FAD and a small portion of it as FMN.
  • 49. Phase III: In this last phase, cells get disrupted by a process of autolysis. This allows release of FAD, FMN and free riboflavin into the medium. • Recovery: Riboflavin is found in fermentation broth and in a bound form to the cells. The latter can be released by heat treatment i.e. 120°C for about 1 hour. • The cells can be discarded after filtration or centrifugation. The filtrate can be further purified and dried, as per the requirements.
  • 50. STATINS  Hyper-lipoproteinemias (HPL) are conditions in which the concentration of cholesterol or triglyceride carrying lipoproteins in the plasma is elevated above normal.  Increase in lipoprotein can hasten the development of atherosclerosis and is a risk factors for myocardial infarction (MI)  Lipids and proteins form complexes called lipoproteins & circulate in blood vessels.
  • 51. Hypolipidaemias • These are the drugs which lower the levels of lipids and lipoproteins in blood used to prevent cardiovascular disease by retarding the atherosclerosis in hyper-lipidaemia individuals • Drugs used to treat hyperlipidaemia are  Lovastatin, Simvastatin, Atorvastatin  Cholestyramine, Colestipol  Clofibrate, Gemfibrozil  Nicotinic Acid
  • 52.
  • 53. Mechanism of Action of Statins (HMG CoA reductase Inhibitors) • Hydroxymethyl glutaryl CoA is the rate controlling enzyme in the biosynthesis of cholesterol • Lovastatin and its congeners are structurally similar to HMG CoA and therefore competitive inhibitors of the enzyme HMG-CoA reductase. The synthesis of cholesterol in the liver is reduced. There is an increase in the expression of hepatic LDL receptor. So that more of LDL is taken up from the circulation. As a result plasma levels of LDL cholesterol and triglycerides fall. • Concentration of HDL- cholesterol increases by 10%
  • 54. Statins Inhibit the HMG CoA reductase Decrease synthesis of Cholesterol Decrease LDL Statins to be useful lowering morbidity and mortality in patients with coronary heart disease. Hence they are used in patients with MI, angina etc
  • 55.  Lovastatin was the first statin drug which was approved by USFDA In the year 1987  It is a potent drug that is used to control increased serum cholesterol level, there by preventing hypercholesterolemia and associated health issue.  It is a competitive inhibitor of the enzyme HMG CoA reductase which catalyses rate limiting step in cholesterol biosynthesis
  • 56. Fungal organism reported for lovastatin production • Aspergillus • Penicillium citrinum • Monascus ruber • Trichoderma • Pleurotus widely reported soil fungi capable of lovastatin production • Commercial production of lovastatin employs a Aspergillus terreus soil fungus • Several production media have been evaluated for lovastatin production by SmF ( submerged fermentation) • Increased yield by supplementation with carbon, nitrogen, aminoacids, vitamins, etc.
  • 57. Fermentation Techniques • Different fermentation techniques including solid state fermentation (SSF) and submerged fermentation (SMF) can be used for statin production. • Large scale commercial production utilises submerged batch fermentation • There is a controlled aeration & agitation in a bioreactor during SMF, which increases the oxygen mass transfer and constant distribution of nutrients to fungal mycelia, resulting in increased production of statins.
  • 58.
  • 59.
  • 60. Wheat bran (40g) as substrate Inoculated with spore suspension (107/8ml spores) of A. terreus (KM017963) Incubated at 280C for 7 days Materials and Methods Culturing of Aspergillus terreus by Solid State Fermentation (SSF)
  • 61. EXTRACTION Inoculated substrate was dried at 40◦C for 24h Crushed to powder Ethyl acetate (150 ml) was added Filtrate was dried using rotary vacuum evaporator
  • 62. Purification of lovastatin One gram of dried crude lovastatin extract was loaded on to pre- packed silica gel column Elution with benzene (100%), and combination of Benzene: Acetonitrile in the following ratio 95:5, 90:10, 85:15, 80:20 Acetonitrile (100%) Thin Layer Chromatography (TLC)
  • 63. Detection of Lovastatin by Thin Layer Chromatography (TLC) Organic phase (20 µl) was spotted on TLC plate Dichloromethane: Ethyl acetate (70:30) Rf comparison with standard Lovastatin